Increased expression of insulin receptor substrate-1 in human pancreatic cancer

Uwe Bergmann, Hitoshi Funatomi, Marko Kornmann, Hans G. Beger, Murray Korc

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Insulin receptor substrate-1 (IRS-1) is a multisite docking protein implicated in mitogenic signaling following activation of the insulin and insulin-like growth factor I receptors. In the present study we characterized IRS-1 expression in human pancreatic cancer. Northern blot analysis revealed high levels of IRS-1 mRNA transcripts in ASPC-1 and MIA PaCa-2 human pancreatic cancer cell lines, and lower levels in COLO-357, PANC-1, and T3M4 cells. Immunoblotting with anti-IRS-1 antibodies indicated that IRS-1 protein levels paralleled IRS-1 mRNA levels. Analysis of RNA isolated from normal and cancerous human pancreatic tissues indicated that 7 of 16 pancreatic cancer samples overexpressed IRS-1 mRNA transcripts by comparison with the normal pancreas and that insulin mRNA levels were abundant in many tumors. These data suggest that IRS-1 contributes to the signaling pathways that lead to excessive growth stimulation in human pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)886-890
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume220
Issue number3
DOIs
StatePublished - Mar 27 1996
Externally publishedYes

Fingerprint

Insulin Receptor Substrate Proteins
Pancreatic Neoplasms
Messenger RNA
Insulin
IGF Type 1 Receptor
Immunoblotting
Northern Blotting
Tumors
Pancreas
Chemical activation
Cells
RNA
Tissue
Cell Line
Antibodies

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Increased expression of insulin receptor substrate-1 in human pancreatic cancer. / Bergmann, Uwe; Funatomi, Hitoshi; Kornmann, Marko; Beger, Hans G.; Korc, Murray.

In: Biochemical and Biophysical Research Communications, Vol. 220, No. 3, 27.03.1996, p. 886-890.

Research output: Contribution to journalArticle

Bergmann, Uwe ; Funatomi, Hitoshi ; Kornmann, Marko ; Beger, Hans G. ; Korc, Murray. / Increased expression of insulin receptor substrate-1 in human pancreatic cancer. In: Biochemical and Biophysical Research Communications. 1996 ; Vol. 220, No. 3. pp. 886-890.
@article{1a2a10c1a9db445d9651122779a96370,
title = "Increased expression of insulin receptor substrate-1 in human pancreatic cancer",
abstract = "Insulin receptor substrate-1 (IRS-1) is a multisite docking protein implicated in mitogenic signaling following activation of the insulin and insulin-like growth factor I receptors. In the present study we characterized IRS-1 expression in human pancreatic cancer. Northern blot analysis revealed high levels of IRS-1 mRNA transcripts in ASPC-1 and MIA PaCa-2 human pancreatic cancer cell lines, and lower levels in COLO-357, PANC-1, and T3M4 cells. Immunoblotting with anti-IRS-1 antibodies indicated that IRS-1 protein levels paralleled IRS-1 mRNA levels. Analysis of RNA isolated from normal and cancerous human pancreatic tissues indicated that 7 of 16 pancreatic cancer samples overexpressed IRS-1 mRNA transcripts by comparison with the normal pancreas and that insulin mRNA levels were abundant in many tumors. These data suggest that IRS-1 contributes to the signaling pathways that lead to excessive growth stimulation in human pancreatic cancer.",
author = "Uwe Bergmann and Hitoshi Funatomi and Marko Kornmann and Beger, {Hans G.} and Murray Korc",
year = "1996",
month = "3",
day = "27",
doi = "10.1006/bbrc.1996.0500",
language = "English (US)",
volume = "220",
pages = "886--890",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Increased expression of insulin receptor substrate-1 in human pancreatic cancer

AU - Bergmann, Uwe

AU - Funatomi, Hitoshi

AU - Kornmann, Marko

AU - Beger, Hans G.

AU - Korc, Murray

PY - 1996/3/27

Y1 - 1996/3/27

N2 - Insulin receptor substrate-1 (IRS-1) is a multisite docking protein implicated in mitogenic signaling following activation of the insulin and insulin-like growth factor I receptors. In the present study we characterized IRS-1 expression in human pancreatic cancer. Northern blot analysis revealed high levels of IRS-1 mRNA transcripts in ASPC-1 and MIA PaCa-2 human pancreatic cancer cell lines, and lower levels in COLO-357, PANC-1, and T3M4 cells. Immunoblotting with anti-IRS-1 antibodies indicated that IRS-1 protein levels paralleled IRS-1 mRNA levels. Analysis of RNA isolated from normal and cancerous human pancreatic tissues indicated that 7 of 16 pancreatic cancer samples overexpressed IRS-1 mRNA transcripts by comparison with the normal pancreas and that insulin mRNA levels were abundant in many tumors. These data suggest that IRS-1 contributes to the signaling pathways that lead to excessive growth stimulation in human pancreatic cancer.

AB - Insulin receptor substrate-1 (IRS-1) is a multisite docking protein implicated in mitogenic signaling following activation of the insulin and insulin-like growth factor I receptors. In the present study we characterized IRS-1 expression in human pancreatic cancer. Northern blot analysis revealed high levels of IRS-1 mRNA transcripts in ASPC-1 and MIA PaCa-2 human pancreatic cancer cell lines, and lower levels in COLO-357, PANC-1, and T3M4 cells. Immunoblotting with anti-IRS-1 antibodies indicated that IRS-1 protein levels paralleled IRS-1 mRNA levels. Analysis of RNA isolated from normal and cancerous human pancreatic tissues indicated that 7 of 16 pancreatic cancer samples overexpressed IRS-1 mRNA transcripts by comparison with the normal pancreas and that insulin mRNA levels were abundant in many tumors. These data suggest that IRS-1 contributes to the signaling pathways that lead to excessive growth stimulation in human pancreatic cancer.

UR - http://www.scopus.com/inward/record.url?scp=0029890372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029890372&partnerID=8YFLogxK

U2 - 10.1006/bbrc.1996.0500

DO - 10.1006/bbrc.1996.0500

M3 - Article

C2 - 8607861

AN - SCOPUS:0029890372

VL - 220

SP - 886

EP - 890

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -